Tags

Type your tag names separated by a space and hit enter

Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):256-257.EH

Authors+Show Affiliations

Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7AL, UK. Physiological Laboratory, University of Cambridge, Cambridge, UK.

Pub Type(s)

Letter
Comment

Language

eng

PubMed ID

32347923

Citation

Jeevaratnam, Kamalan. "Chloroquine and Hydroxychloroquine for COVID-19: Implications for Cardiac Safety." European Heart Journal. Cardiovascular Pharmacotherapy, vol. 6, no. 4, 2020, pp. 256-257.
Jeevaratnam K. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety. Eur Heart J Cardiovasc Pharmacother. 2020;6(4):256-257.
Jeevaratnam, K. (2020). Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety. European Heart Journal. Cardiovascular Pharmacotherapy, 6(4), 256-257. https://doi.org/10.1093/ehjcvp/pvaa041
Jeevaratnam K. Chloroquine and Hydroxychloroquine for COVID-19: Implications for Cardiac Safety. Eur Heart J Cardiovasc Pharmacother. 2020 07 1;6(4):256-257. PubMed PMID: 32347923.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety. A1 - Jeevaratnam,Kamalan, PY - 2020/04/08/received PY - 2020/04/15/revised PY - 2020/04/21/accepted PY - 2020/4/30/pubmed PY - 2020/7/21/medline PY - 2020/4/30/entrez SP - 256 EP - 257 JF - European heart journal. Cardiovascular pharmacotherapy JO - Eur Heart J Cardiovasc Pharmacother VL - 6 IS - 4 SN - 2055-6845 UR - https://www.unboundmedicine.com/medline/citation/32347923/Chloroquine_and_hydroxychloroquine_for_COVID_19:_implications_for_cardiac_safety_ L2 - https://academic.oup.com/ehjcvp/article-lookup/doi/10.1093/ehjcvp/pvaa041 DB - PRIME DP - Unbound Medicine ER -